Perceptive Advisors LLC
- SEC CIK
- 0001224962
- Latest filing
- Aug 14, 2026
Holdings in Q1 2021
Holdings as of Mar 31, 2021, filed Aug 13, 2021. Long positions only.
- Positions
- 136
- No 13F data for Q4 2020
- Portfolio value
- $7.52B
- No 13F data for Q4 2020
Livermore's 13F data starts with Q1 2021, so this quarter has no previous quarter to compare with and changes are not shown.
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| MRTXMirati Therapeutics, Inc. | COM | 3,474,505 | $595.2M | 7.9% | – | – | History |
| BBIOBridgeBio Pharma, Inc. | COM | 7,756,928 | $477.8M | 6.4% | – | – | History |
| Retrophin Inc761299AB2 | NOTE 2.500% 9/1 | – | $474.8M | 6.3% | – | – | – |
| SWTXSpringWorks Therapeutics, Inc. | COM | 4,849,912 | $356.8M | 4.7% | – | – | History |
| IOVAIovance Biotherapeutics, Inc. | COM | 8,651,785 | $273.9M | 3.6% | – | – | History |
| FOLDAmicus Therapeutics, Inc. | COM | 22,861,329 | $225.9M | 3.0% | – | – | History |
| GBTGlobal Blood Therapeutics, Inc. | COM | 5,058,642 | $206.1M | 2.7% | – | – | History |
| NVTAInvitae Corp | COM | 5,360,673 | $204.8M | 2.7% | – | – | History |
| Collegium Pharmaceutical, Inc19459JAA2 | NOTE 2.625% 2/1 | – | $189.6M | 2.5% | – | – | – |
| HZNPHorizon Therapeutics Public Ltd Co | SHS | 2,050,002 | $188.7M | 2.5% | – | – | History |
| AVIRAtea Pharmaceuticals, Inc. | COM | 3,109,224 | $184.7M | 2.5% | – | – | History |
| VBIVVBI Vaccines Inc/BC | COM NEW | 55,042,465 | $171.2M | 2.3% | – | – | History |
| LABPLandos Biopharma, Inc. | COM | 14,869,915 | $141.0M | 1.9% | – | – | History |
| ZYMEZymeworks Inc. | COM | 4,330,868 | $136.8M | 1.8% | – | – | History |
| Nevro Corp64157FAC7 | NOTE 2.750% 4/0 | – | $135.3M | 1.8% | – | – | – |
| OMOutset Medical, Inc. | COM | 2,387,535 | $129.9M | 1.7% | – | – | History |
| RCKTRocket Pharmaceuticals, Inc. | COM | 2,867,771 | $127.2M | 1.7% | – | – | History |
| CCCCC4 Therapeutics, Inc. | COM STK | 3,158,566 | $116.8M | 1.6% | – | – | History |
| NVRONevro Corp | COM | 812,154 | $113.3M | 1.5% | – | – | History |
| ALDXAldeyra Therapeutics, Inc. | COM | 8,703,879 | $103.4M | 1.4% | – | – | History |
| MGTXMeiraGTx Holdings plc | COM | 6,933,277 | $93.4M | 1.2% | – | – | History |
| NBIXNeurocrine Biosciences Inc | Stock | 941,832 | $91.6M | 1.2% | – | – | History |
| ALBOAlbireo Pharma, Inc. | COM | 2,360,139 | $83.2M | 1.1% | – | – | History |
| TVTXTravere Therapeutics, Inc. | COM | 3,298,419 | $82.4M | 1.1% | – | – | History |
| KRONKronos Bio, Inc. | COM | 2,780,097 | $79.7M | 1.1% | – | – | History |
| SLDBSolid Biosciences Inc. | COM | 13,412,552 | $74.2M | 1.0% | – | – | History |
| RLAYRelay Therapeutics, Inc. | COM | 2,018,097 | $69.8M | 0.9% | – | – | History |
| CHRSCoherus Oncology, Inc. | COM | 4,697,612 | $68.6M | 0.9% | – | – | History |
| MGNXMacrogenics Inc | COM | 2,148,060 | $68.4M | 0.9% | – | – | History |
| CERECerevel Therapeutics Holdings, Inc. | COM | 4,643,095 | $63.7M | 0.8% | – | – | History |
| LONALeonaBio, Inc. | COM | 3,425,916 | $63.0M | 0.8% | – | – | History |
| ESTAEstablishment Labs Holdings Inc. | COM | 987,287 | $61.7M | 0.8% | – | – | History |
| KDMNKadmon Holdings, Inc. | COM | 15,711,334 | $61.1M | 0.8% | – | – | History |
| NARIInari Medical, Inc. | Stock | 565,113 | $60.5M | 0.8% | – | – | History |
| QTNTQuotient Ltd | SHS | 16,200,818 | $59.6M | 0.8% | – | – | History |
| MORFMorphic Holding, Inc. | COM | 938,140 | $59.4M | 0.8% | – | – | History |
| ATNXAthenex, Inc. | COM | 13,532,467 | $57.3M | 0.8% | – | – | History |
| RXDXPrometheus Biosciences, Inc. | COM | 3,314,032 | $55.4M | 0.7% | – | – | History |
| RAPTRAPT Therapeutics, Inc. | COM | 2,477,481 | $55.0M | 0.7% | – | – | History |
| VRCAVerrica Pharmaceuticals Inc. | COM | 3,610,412 | $54.7M | 0.7% | – | – | History |
| CRNXCrinetics Pharmaceuticals, Inc. | COM | 3,659,381 | $51.6M | 0.7% | – | – | History |
| VERUVeru Inc. | COM | 4,451,342 | $48.0M | 0.6% | – | – | History |
| EXASExact Sciences Corp | COM | 353,523 | $46.6M | 0.6% | – | – | History |
| YARWYarrow Bioscience, Inc. | COM | 6,773,954 | $46.4M | 0.6% | – | – | History |
| KODKodiak Sciences Inc. | COM | 389,008 | $44.1M | 0.6% | – | – | History |
| TARSTarsus Pharmaceuticals, Inc. | COM | 1,296,416 | $41.1M | 0.5% | – | – | History |
| DBVTDBV Technologies S.A. | SPONSORED ADR | 7,695,505 | $41.0M | 0.5% | – | – | History |
| ALLOAllogene Therapeutics, Inc. | COM | 1,143,790 | $40.4M | 0.5% | – | – | History |
| ARNAArena Pharmaceuticals Inc | COM NEW | 575,007 | $39.9M | 0.5% | – | – | History |
| BEAMBeam Therapeutics Inc. | COM | 537,635 | $37.8M | 0.5% | – | – | History |
| LYRALyra Therapeutics, Inc. | COM | 3,222,560 | $37.3M | 0.5% | – | – | History |
| ACADAcadia Pharmaceuticals Inc | COM | 1,410,305 | $36.4M | 0.5% | – | – | History |
| FMTXForma Therapeutics Holdings, Inc. | SHS | 1,250,000 | $35.0M | 0.5% | – | – | History |
| AGRXAgile Therapeutics Inc | COM | 15,919,925 | $33.1M | 0.4% | – | – | History |
| PRVBProvention Bio, Inc. | COM | 2,852,058 | $29.9M | 0.4% | – | – | History |
| CMPSCOMPASS Pathways plc | SPONSORED ADS | 797,404 | $29.4M | 0.4% | – | – | History |
| UTHRUnited Therapeutics Corp | COM | 175,000 | $29.3M | 0.4% | – | – | History |
| ADMAAdma Biologics, Inc. | COM | 16,584,802 | $29.2M | 0.4% | – | – | History |
| NUVBNuvation Bio Inc. | COM CL A | 3,041,004 | $29.0M | 0.4% | – | – | History |
| ISEEIVERIC bio, Inc. | COM | 4,585,512 | $28.3M | 0.4% | – | – | History |
| IMTXImmatics N.V. | SHS | 2,500,000 | $28.0M | 0.4% | – | – | History |
| COGTCogent Biosciences, Inc. | COM | 3,188,750 | $28.0M | 0.4% | – | – | History |
| ONCROncorus, Inc. | COM | 1,989,987 | $27.7M | 0.4% | – | – | History |
| ARWRArrowhead Pharmaceuticals, Inc. | COM | 409,341 | $27.1M | 0.4% | – | – | History |
| STOKStoke Therapeutics, Inc. | COM | 671,978 | $26.1M | 0.3% | – | – | History |
| ATECAlphatec Holdings, Inc. | COM NEW | 1,800,180 | $25.5M | 0.3% | – | – | History |
| PMVPPMV Pharmaceuticals, Inc. | COM | 746,557 | $24.6M | 0.3% | – | – | History |
| VRNAVerona Pharma plc | SPONSORED ADS | 2,888,889 | $24.2M | 0.3% | – | – | History |
| Avidity Biosciences, Inc.05370A108 | COM | 1,099,028 | $24.0M | 0.3% | – | – | – |
| HCATHealth Catalyst, Inc. | COM | 506,084 | $23.7M | 0.3% | – | – | History |
| FBRXForte Biosciences, Inc. | COM | 685,000 | $23.5M | 0.3% | – | – | History |
| COLLCollegium Pharmaceutical, Inc | COM | 978,277 | $23.2M | 0.3% | – | – | History |
| FUSNFusion Pharmaceuticals Inc. | COM | 1,950,167 | $20.9M | 0.3% | – | – | History |
| DRNADicerna Pharmaceuticals Inc | COM | 800,000 | $20.5M | 0.3% | – | – | History |
| ONEM1Life Healthcare Inc | COM | 519,844 | $20.3M | 0.3% | – | – | History |
| MREOMereo BioPharma Group plc | SPON ADS | 6,000,000 | $20.2M | 0.3% | – | – | History |
| KRROKorro Bio, Inc. | COM | 2,113,661 | $20.1M | 0.3% | – | – | History |
| FDMT4D Molecular Therapeutics, Inc. | COM | 444,878 | $19.3M | 0.3% | – | – | History |
| SILKSilk Road Medical Inc | COM | 340,100 | $17.2M | 0.2% | – | – | History |
| IMCRImmunocore Holdings plc | ADS | 400,000 | $17.0M | 0.2% | – | – | History |
| PCVXVaxcyte, Inc. | COM | 850,000 | $16.8M | 0.2% | – | – | History |
| CTMXCytomX Therapeutics, Inc. | COM | 2,153,974 | $16.6M | 0.2% | – | – | History |
| NEPTFNeptune Wellness Solutions Inc. | COM | 12,849,706 | $16.6M | 0.2% | – | – | History |
| ACRSAclaris Therapeutics, Inc. | COM | 650,000 | $16.4M | 0.2% | – | – | History |
| CYPHCypherpunk Technologies Inc. | COM | 8,476,496 | $16.1M | 0.2% | – | – | History |
| CM Life Sciences II Inc125842203 | UNIT 02/25/2028 | 1,250,000 | $16.0M | 0.2% | – | – | – |
| NBTXNanobiotix S.A. | SPONSORED ADS | 1,059,800 | $15.9M | 0.2% | – | – | History |
| Therapeutics Acquisition Cor88339T103 | COM CL A | 1,500,000 | $15.8M | 0.2% | – | – | – |
| ACCDAccolade, Inc. | COM | 345,741 | $15.7M | 0.2% | – | – | History |
| HYPRHyperfine, Inc. | CL A SHS | 1,500,000 | $14.9M | 0.2% | – | – | History |
| ADPTAdaptive Biotechnologies Corp | COM | 352,804 | $14.2M | 0.2% | – | – | History |
| VTRSViatris Inc | Stock | 1,004,419 | $14.0M | 0.2% | – | – | History |
| Achilles Therapeutics PLC00449L102 | SPONSORED ADS | 755,375 | $12.5M | 0.2% | – | – | – |
| CNCEConcert Pharmaceuticals, Inc. | COM | 2,150,641 | $10.7M | 0.1% | – | – | History |
| BCLS Acquisition CorpG0904B105 | COM CL A | 1,000,000 | $10.6M | 0.1% | – | – | – |
| CLOVClover Health Investments, Corp. | COM CL A | 1,500,000 | $10.3M | 0.1% | – | – | History |
| HRMYHarmony Biosciences Holdings, Inc. | COM | 311,673 | $10.3M | 0.1% | – | – | History |
| RACBResearch Alliance Corp. II | COM CL A | 1,000,000 | $10.3M | 0.1% | – | – | History |
| TSHATaysha Gene Therapies, Inc. | COM SHS | 470,440 | $9.55M | 0.1% | – | – | History |
| XENEXenon Pharmaceuticals Inc. | COM | 515,042 | $9.22M | 0.1% | – | – | History |
Options (2)
Puts and calls in the same filing. Amounts are the market value of the underlying shares, which is what 13F reports.